Pfizer in Europe

Pfizer's expansion into Europe began in the mid-20th century, with the establishment of its first European offices and manufacturing facilities across various countries. Pfizer had a pivotal role in the mass production of penicillin during World War II, which helped revolutionize medicine and save countless lives. Growth in Europe has been characterized by strategic acquisitions, partnerships, and R&D investments that solidified its position as a leading partner in European healthcare.

Our European Footprint

Resilience in Patient Supply

Pfizer’s ability to meet patient needs in Europe and around the globe depends on a stable, pro-innovation policy environment and the ability to maintain a supply chain that is both flexible and resilient.

Resilience and Innovation in Patient Supply

Invested in Europe

With a presence in Europe since the 1950’s, Pfizer has invested significantly in our workforce and operations across the continent.

Invested In Europe